Progranulin protects against Clostridioides difficile infection by enhancing IL-22 production.
Ontology highlight
ABSTRACT: Enhanced mortality, relapse rates, and increased prevalence of Clostridioides difficile infection (CDI) emphasize the need for better therapies and management approaches. Modulating host immune response to ameliorate CDI-associated immunopathology may provide new advantages to currently inadequate antibiotic therapies. Here, we identified progranulin (PGRN) as an important immune target upregulated in response to CDI. PGRN-deficient mice displayed dramatically higher mortality and aggravated epithelial barrier disruption compared with wild type (WT) mice after CDI despite equivalent levels of bacterial burden or toxin in the large intestine. Mechanistically, PGRN protection was mediated by IL-22 production from CD4+ T helper cells, as demonstrated by a decrease in colonic
SUBMITTER: Huang J
PROVIDER: S-EPMC11444516 | biostudies-literature | 2024 Jan-Dec
REPOSITORIES: biostudies-literature
ACCESS DATA